Alice Fan
Academic Appointments
- Instructor, Medicine - Oncology
Contact Information
-
Clinical Offices
Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-9113
Professional Snapshot
Clinical Focus
- Cancer > Lymphoma
- Medical Oncology
- Oncology (Cancer)
Administrative Appointments
- Co-Director, Stanford Firefly Instrument for Nano-scale protein detection (2008 - present)
Honors and Awards
- Special Fellow in Clinical Research, Leukemia and Lymphoma Society (July 2006-June 2009)
- Research Fellowship, Lymphoma Research Foundation (July 2004-June 2006)
- Dean's Fellowship, Stanford School of Medicine (April 2004- March 2005)
Professional Education
| Fellowship: | Stanford University Medical Center, CA (2006) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2004) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2001) |
| Residency: | Brown University - School of Medicine, RI (2001) |
| Internship: | Brown University - School of Medicine, RI (1999) |
Graduate & Fellowship Program Affiliations
Community & International Work
Scientific Focus
Research Interests
Dr. Fan studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical studies. Based on preclinical findings, she has initiated a clinical trial studying atorvastatin for the treatment of patients with certain non-Hodgkin's lymphomas. In the laboratory, she also uses preclinical models of cancer to validate new nanotechnology strategies for tumor diagnosis and treatment.
Clinical Trials
Publications
- Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew Chem Int Ed Engl. 2009; (41): 7668-72
- Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat Med. 2009; (5): 566-71
- Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. PLoS One. 2008; (5): e2125
- A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice. Mol Cancer. 2008: 74
- Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci U S A. 2007; (32): 13028-33
Help